The chapter discusses the critical functions of NAD in cellular metabolism, focusing on its role as an electron acceptor for energy conversion. It explores how maintaining a balance of NAD coenzymes is essential for optimal cellular function and energy production. Additionally, it highlights the potential benefits of nicotinamide riboside in protecting against nerve damage and touches on its impact on cancer models.
Charles Brenner, PhD is the chair of the new Department of Diabetes & Cancer Metabolism at the Beckman Research Institute of the City of Hope National Medical Center. He is a major contributor to work on nicotinamide adenine dinucleotide metabolism, who discovered the eukaryotic nicotinamide riboside (NR) kinase pathway.